Escherichia coli infection
MONDO:0020920Infection with the organism Escherichia Coli.
Also known as: e coli infection, escherichia coli infection, Bacterial infection caused by E. coli, Bacterial infection due to E. coli, Colibacillosis, E COLI INFECT, E Coli Infection, E coli Infection
65 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New vaccine shows promise against Traveler's diarrhea in early trial
⭐️ VACCINE ⭐️ CompletedThis study tested an experimental vaccine (CssBA+dmLT) to see if it can prevent moderate-to-severe diarrhea caused by ETEC bacteria, a common cause of traveler's diarrhea. About 72 healthy adults received either the vaccine or a placebo, then were exposed to the bacteria in a con…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:09 UTC
-
New oral vaccine aims to tackle two Diarrhea-Causing bugs at once
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a new oral vaccine designed to protect against two bacteria that cause severe diarrhea: Shigella and ETEC. Fifty-three healthy adults received the vaccine to check for side effects and to see if it triggers an immune response. The goal is to develop …
Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:01 UTC
-
New combo vaccine targets deadly diarrhea in kids
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine called ShigETEC in healthy adults and children in Bangladesh. The vaccine aims to protect against two bacteria that cause severe diarrhea: Shigella and ETEC. Researchers gave three doses of the vaccine or a placebo to 196 participants to check if i…
Phase: PHASE1 • Sponsor: Eveliqure Biotechnologies GmbH • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:13 UTC
-
New oral vaccine targets Traveler's diarrhea
⭐️ VACCINE ⭐️ CompletedThis early-stage trial tests a new oral vaccine (dmLT) designed to protect against diarrhea caused by a harmful type of E. coli. About 36 healthy adults aged 18-45 will receive one of four vaccine doses. Researchers will monitor safety, side effects, and immune response over abou…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:53 UTC
-
Could a simple tablet stop Travelers' diarrhea before it starts?
Disease control CompletedThis study tested whether a daily dose of Travelan (IMM-124E) tablets could prevent moderate-to-severe diarrhea in healthy adults deliberately infected with ETEC bacteria, a common cause of travelers' diarrhea. Sixty-three volunteers took either Travelan or a placebo for 7 days. …
Phase: PHASE2 • Sponsor: Immuron Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New antibiotic GSK3882347 tested for UTIs in early trial
Disease control CompletedThis early-stage trial tested an experimental antibiotic called GSK3882347 in 140 women with uncomplicated urinary tract infections (UTIs). Participants received either the new drug, a standard antibiotic (nitrofurantoin), or a placebo for 5 days. The study measured how well the …
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Low-Cost cabinet cuts child diarrhea risk in bangladesh
Disease control CompletedThis study tested whether a low-cost food storage cabinet called a "meatsafe" could reduce diarrhea in children aged 6 to 24 months in low-income areas of Dhaka, Bangladesh. Researchers compared households that received the cabinet and food safety education to those that did not.…
Phase: NA • Sponsor: University of California, Berkeley • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Rural patients get Hospital-Level care at home in landmark trial
Disease control CompletedThis study looked at whether giving hospital-level care to acutely ill adults in their own homes in rural areas works well. 160 people with various conditions like infections, heart failure, or COPD took part. The goal was to see if this approach could lower costs and help patien…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New rapid test for infection and inflammation put to the test
Diagnosis CompletedThis study looked at how well a new, quick finger-prick test (LumiraDx CRP) measures CRP levels compared to a standard lab test. CRP is a marker of infection, inflammation, or tissue injury. 79 adults with symptoms of these conditions took part. The goal was to see if the new tes…
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New PET scan technique aims to sniff out hidden infections
Diagnosis CompletedThis early study tested whether a special PET scan using a radioactive form of vitamin B9 (11C-PABA) can help doctors see infections deep inside the body. Researchers scanned 13 healthy people and patients with known or suspected infections. The goal was to see if this method can…
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
New vaccine aims to stop dangerous e. coli infections in seniors
Prevention CompletedThis large Phase 3 trial tested a vaccine called ExPEC9V in nearly 18,000 adults aged 60 and older who had a urinary tract infection in the past two years. The goal was to see if the vaccine could prevent invasive E. coli disease, a serious infection that can spread to the blood …
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Prevention
Last updated Jun 27, 2026 13:02 UTC
-
One shot, two protections? new study combines e. coli and flu vaccines for seniors
Prevention CompletedThis study tested whether a new vaccine against certain E. coli bacteria (ExPEC9V) can be given at the same time as a high-dose flu shot in adults aged 65 and older. The goal was to see if the immune response to both vaccines remains strong when given together. About 959 particip…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Cranberry capsules tested to stop catheter infections after surgery
Prevention CompletedThis study looked at whether cranberry gel capsules can prevent E. coli infections from urinary catheters placed during pelvic surgery. About 270 adults took part. The idea was that cranberry might stop bacteria from sticking to the catheter, reducing infection risk.
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
Probiotic shows promise in easing antibiotic side effects in kids
Symptom relief CompletedThis study tested whether a probiotic called Bifidobacterium breve PRL2020 could reduce stomach issues like diarrhea in 121 children aged 3-12 who were taking amoxicillin antibiotics. The children took the probiotic alongside their antibiotic treatment. The goal was to see if it …
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Tracking superbugs from mother to baby: a chicago study
Knowledge-focused CompletedThis study looks at how drug-resistant bacteria, specifically ESBL-producing E. coli, are passed from mothers to their newborns during vaginal birth or scheduled C-sections. Researchers will test stool samples from 200 healthy mothers and their babies at a Chicago hospital to see…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Study links NSAIDs to severe bacterial infections
Knowledge-focused CompletedThis study looked at 335 adults hospitalized with bacterial infections to see if taking NSAIDs (like ibuprofen) before admission made their infections more severe. Researchers compared those with complicated infections (abscesses, needing surgery) to those with simpler infections…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Can friendly gut bacteria beat superbugs? new study explores natural decolonization
Knowledge-focused CompletedThis study followed 39 travelers to Southeast Asia to see if their guts naturally clear a type of antibiotic-resistant E. coli (ESBL E. coli) over time. Participants provided stool samples before and after travel and up to a year later. The goal was to understand how the body's o…
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists seek perfect antibiotic dose for young burn victims
Knowledge-focused CompletedThis study aimed to find the best dose of the antibiotic ceftazidime for critically ill children with severe burns. Researchers took blood samples from 3 children to measure how the drug moves through the body. The goal was to learn how to personalize dosing to improve treatment …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New antibiotic studied in kids: first step toward better infection treatment
Knowledge-focused CompletedThis early-phase study tested a single dose of the antibiotic omadacycline (Nuzyra) in 23 children aged 8 to 17 who were hospitalized with bacterial infections. Researchers measured how the drug moved through the body and checked for side effects. The goal was to gather safety an…
Phase: PHASE1 • Sponsor: Paratek Pharmaceuticals Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New imaging method could spot hidden bacteria
Knowledge-focused CompletedThis study tested a new imaging technique using a radioactive tracer called 11C-trimethoprim to see how it spreads in the bodies of 16 adults with suspected bacterial infections. Participants had PET/CT scans to track the tracer over time. The goal was to learn how the tracer beh…
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
ICU antibiotic dosing: what really matters?
Knowledge-focused CompletedThis study looked at 156 critically ill patients to find out what factors help achieve the right levels of beta-lactam antibiotics in the blood. Researchers collected clinical data and used therapeutic drug monitoring to see which patients reached target concentrations. The goal …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Wearable pump trial aims to free hospital patients from IV stands
Knowledge-focused CompletedThis study tested special wearable pumps (elastomeric pumps) to give antibiotics through a drip to hospital patients. Nine adults with bacterial infections took part to see if the pumps are safe, easy to use, and could save time and money compared to traditional methods. The goal…
Phase: NA • Sponsor: Stuart Bond • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC